This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
Systematic and comprehensive analysis of mutant p53 proteins in lung cancer in vitro and in vivo.
CIHR · 2017 · Principal investigator
Systematic and comprehensive analysis of mutant p53 proteins in lung cancer in vitro and in vivo.
Principal investigators: Schramek, Daniel; Oren, Moshe
Keywords: Lumier; Lung Cancer; Mass Spectrometry Bioid/Ap-Ms; Mouse Models; P53 Gain-Of-Function; P53 Mutations
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.